Mirum Pharmaceuticals beat expectations again with strong Livmarli growth and raised guidance, earning bullish analyst ...

Peyto Exploration & Development Corp (TSX:PEY) is set to release its Q2 2025 earnings on Aug 12, 2025. The consensus estimate ...

Neo Performance Materials Inc (TSX:NEO) is set to release its Q2 2025 earnings on August 12, 2025. The consensus estimate for ...

Shares of monday.com (NASDAQ:MNDY) fell about 20% premarket on Monday despite second quarter results beating estimates. The ...

Amazon's Q2 results highlight growth in cloud, ads & 3rd party sales. Discover why analysts see up to 93% upside potential in ...

Dole plc (NYSE:DOLE) gained in early trading on Monday after reporting solid results for its second quarter. Revenue rose ...

Quantum stocks grabbed the attention of investors and analysts last week as second-quarter earnings reports came in.

European companies are proving they can just about endure U.S. import tariffs, eking out earnings growth for a fifth straight ...

GAAP revenue for Q2 2025 was $161.1 million, falling short of analyst estimates of $164.5 million. Adjusted diluted EPS (non-GAAP) for Q2 2025 was $0.51, slightly above the consensus estimate of $0.50 ...

Baron Funds, an investment management company, released its Q2 2025 investor letter. Here is what the fund said: “Within IT, ...

We anticipate Phase IIa trials will launch in Q3 2025, which we believe will allow Oragenics to maintain a significant ...

Q2 2025 losses to the incremental costs of new projects that had not yet entered the operational phase. This is in addition to ...